Carlo Pozzilli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with natalizumab: a multicenter, observational study	NEUROLOGICAL SCIENCES	2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register	MULTIPLE SCLEROSIS	2022
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus	JOURNAL OF NEUROLOGY	2021
Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients	FRONTIERS IN NEUROLOGY	2021
A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration	JOURNAL OF NEUROLOGY	2021
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis	NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION	2021
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis	AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY	2021
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases	FRONTIERS IN NEUROLOGY	2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2021
Ponesimod to treat multiple sclerosis	DRUGS OF TODAY	2021
Multi-scale resting state functional reorganization in response to multiple sclerosis damage	NEURORADIOLOGY	2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2020
Resting-state functional connectivity of anterior and posterior cerebellar lobes is altered in multiple sclerosis	MULTIPLE SCLEROSIS	2020
Cesarean section in women with MS: A choice or a need?	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2020
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial	NEUROTHERAPEUTICS	2020
Multiple sclerosis treatment and melanoma development	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020